dda0e331f093d7051e9cbf173530ac0d8abff2e872bee82a568f021bb8d72eff
Integrated Health-Science IP Portfolio — Full Use & Copy License
Publicly online since 2010 · U.S. patent applications since 2012 · inventions offered since 2014. The work of Christopher Gabriel Brown, independently documented.
This is a full use & copy license for the Integrated Health-Science IP Portfolio — really, a warm invitation to explore, study, and build on the whole health-side body of work at your own pace. The underlying IP and the pending patent applications stay with CRI-ONE / Christopher Gabriel Brown, and everything is shared with you under a simple, executed NDA.
What this is — in plain words
One gentle, single step that lets you take on the entire health-science vertical at once: the discovery engine, the breadth index, the deeper research dossiers, the pending patent estate, and a productized supplement front end — all together, under one chain of title. There's no rush and no pressure; you're welcome to take all the time you need.
What the license includes
- Alchemy Data V2 substrate — the computational elemental-analysis engine and its generator tooling.
- 300-disease screening database — a uniform, machine-generated research index across 300 conditions, offered as a starting map.
- Three disease-mechanism research dossiers — diabetes, Alzheimer's, and Parkinson's elemental-mechanism analyses, each with a filed patent application.
- NeuroElement™ formulation IP — a computationally-designed nootropic formulation (patent-pending) with brand and go-to-market materials.
- OTC vitamin line — the KidVital + VitalCore portfolio.
A gentle suggestion on how to approach it
- Start with the methodology. Each project explains, in plain terms, what its method does and does not establish — we'd gently suggest beginning there.
- Treat the findings as starting points. These are computational research leads to investigate, not finished answers.
- Please validate before you rely. Anything you intend to act on is best confirmed through your own testing and the proper regulatory channels.
- You're warmly encouraged to bring in qualified people — licensed scientific, medical, and regulatory professionals — as you go.
- Go at your own pace. There's a great deal here; there's no need to take it all in at once.
Where the evidence stands — shared openly
- The disease research is computational and early-stage; much of the 300-disease database is exploratory and not yet independently validated.
- The supplements carry structure/function wording only and have not been evaluated by the FDA.
- The three patent applications are pending, not granted. What the bundle offers is integration and one chain of title — gently, not an upgrade of the evidence.
A gentle note
Please take your time, ask any questions you have, and reach out whenever you'd like. There's no obligation here — we're always glad to help you understand exactly what you're considering, and to move at whatever pace feels right for you.
